Obesity Clinical Trial
— HIPPOfficial title:
Promoting Health in Pregnancy and Postpartum Among Overweight/Obese Women
Verified date | April 2021 |
Source | University of South Carolina |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to examine the impact of a lifestyle intervention on gestational weight gain, postpartum weight loss, and other secondary outcomes relative to a usual care control group.
Status | Completed |
Enrollment | 228 |
Est. completion date | November 1, 2020 |
Est. primary completion date | November 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 44 Years |
Eligibility | Inclusion Criteria: - White or African American woman - Overweight or obese (prepregnancy BMI: 25-45 kg/m2) - = 16 wks gestation at screening - Age 18-44 years - No plan to move out of the greater Columbia area in next 18 months - Regular and consistent telephone access - Availability for telephone calls - Willing to accept random assignment Exclusion Criteria: - Uncontrolled hypertension - Fetal anomaly - Taking insulin for diabetes - Uncontrolled or untreated thyroid disease - Mental health or substance-abuse hospitalization in last 6 months - Multiple gestation - Persistent bleeding in the first trimester - History of more than 3 miscarriages - History of an eating disorder or current eating disorder - History of an incompetent cervix - Physical disability that prevents exercise - Told by health care provider not to exercise - Any other medical conditions that might be a contraindication to exercise or dietary change |
Country | Name | City | State |
---|---|---|---|
United States | University of South Carolina Prevention Research Center | Columbia | South Carolina |
Lead Sponsor | Collaborator |
---|---|
University of South Carolina | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Self-efficacy for diet and physical activity | Self-report measure | 32 weeks gestation | |
Other | Self-efficacy for diet and physical activity | Self-report measure | 6 months postpartum | |
Other | Self-efficacy for diet and physical activity | Self-report measure | 12 months postpartum | |
Other | Social support for diet and physical activity | Self-report measure | 32 weeks gestation | |
Other | Social support for diet and physical activity | Self-report measure | 6 months postpartum | |
Other | Social support for diet and physical activity | Self-report measure | 12 months postpartum | |
Other | Decisional balance for diet and physical activity | Self-report measure | 32 weeks gestation | |
Other | Decisional balance for diet and physical activity | Self-report measure | 6 months postpartum | |
Other | Decisional balance for diet and physical activity | Self-report measure | 12 months postpartum | |
Other | Self-regulation for diet and physical activity | Self-report measure | 32 weeks gestation | |
Other | Self-regulation for diet and physical activity | Self-report measure | 6 months postpartum | |
Other | Self-regulation for diet and physical activity | Self-report measure | 12 months postpartum | |
Primary | Gestational weight gain in pounds | Defined as delivery room weight minus pre-pregnancy weight | Delivery | |
Secondary | Gestational weight gain category | Based on delivery room weight minus pre-pregnancy weight and categorized as Inadequate, adequate, excessive | Delivery | |
Secondary | Postpartum weight retention | Defined as weight during 6 month postpartum visit minus pre-pregnancy weight | Weight retained at the 6 month postpartum visit | |
Secondary | Postpartum weight retention | Defined as weight during 12 month postpartum visit minus pre-pregnancy weight | Weight retained at the 12 month postpartum visit | |
Secondary | Physical Activity | Sense Wear Armband and self-report measure will assess physical activity | 32 weeks gestation | |
Secondary | Physical Activity | Sense Wear Armband and self-report measure will assess physical activity | 6 months postpartum | |
Secondary | Physical Activity | Sense Wear Armband and self-report measure will assess physical activity | 12 months postpartum | |
Secondary | Dietary intake | Two 24-hour dietary recalls using the National Cancer Institute's Automated Self-Administered 24-hour Dietary Recall (ASA-24) will assess dietary intake. | 32 weeks gestation | |
Secondary | Dietary intake | Two 24-hour dietary recalls using the National Cancer Institute's Automated Self-Administered 24-hour Dietary Recall (ASA-24) will assess dietary intake. | 6 months postpartum | |
Secondary | Dietary intake | Two 24-hour dietary recalls using the National Cancer Institute's Automated Self-Administered 24-hour Dietary Recall (ASA-24) will assess dietary intake. | 12 months postpartum | |
Secondary | Depressive Symptoms | Depressive symptoms will be assessed with the Edinburgh Prenatal/Postnatal Depression Scale. | 32 weeks gestation | |
Secondary | Depressive Symptoms | Depressive symptoms will be assessed with the Edinburgh Prenatal/Postnatal Depression Scale. | 6 months postpartum | |
Secondary | Depressive Symptoms | Depressive symptoms will be assessed with the Edinburgh Prenatal/Postnatal Depression Scale. | 12 months postpartum | |
Secondary | Health-Related Quality of Life | The Short Form-12 (SF-12) questionnaire will be used to assess quality of life. | 32 weeks gestation | |
Secondary | Health-Related Quality of Life | The Short Form-12 (SF-12) questionnaire will be used to assess quality of life. | 6 months postpartum | |
Secondary | Health-Related Quality of Life | The Short Form-12 (SF-12) questionnaire will be used to assess quality of life. | 12 months postpartum | |
Secondary | Child Adiposity | Z-scores and skinfolds will be used to measure child adiposity. | 6 months postpartum | |
Secondary | Child Adiposity | Z-scores and skinfolds will be used to measure child adiposity. | 12 months postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |